| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 127.75B | 142.26B | 159.51B | 174.97B | 162.53B | 144.76B |
| Gross Profit | 32.11B | 30.27B | 27.38B | 31.93B | 34.29B | 33.02B |
| EBITDA | 18.26B | 18.07B | 15.71B | 18.05B | 21.53B | 21.61B |
| Net Income | 13.32B | 4.15B | -8.50B | 5.68B | 6.70B | 7.28B |
Balance Sheet | ||||||
| Total Assets | 193.21B | 176.37B | 205.82B | 202.18B | 200.19B | 195.72B |
| Cash, Cash Equivalents and Short-Term Investments | 31.02B | 24.53B | 27.24B | 17.11B | 18.17B | 23.65B |
| Total Debt | 3.58B | 3.42B | 10.70B | 10.23B | 7.89B | 9.27B |
| Total Liabilities | 37.72B | 38.06B | 64.24B | 53.19B | 53.16B | 52.77B |
| Stockholders Equity | 152.36B | 135.38B | 139.04B | 146.07B | 144.48B | 140.47B |
Cash Flow | ||||||
| Free Cash Flow | 13.23B | 7.15B | 12.77B | 1.47B | 2.73B | 14.67B |
| Operating Cash Flow | 19.54B | 13.93B | 19.81B | 10.85B | 11.33B | 22.30B |
| Investing Cash Flow | -1.26B | -5.08B | -6.26B | -10.17B | -11.70B | -12.50B |
| Financing Cash Flow | -4.96B | -11.89B | -4.01B | -2.34B | -5.98B | -4.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥175.98B | 15.59 | ― | 2.84% | 4.10% | 5.25% | |
77 Outperform | ¥109.53B | 12.08 | 9.19% | 3.33% | -13.96% | ― | |
77 Outperform | ¥116.77B | 10.07 | ― | 3.72% | 4.93% | 30.22% | |
75 Outperform | ¥171.14B | 10.40 | ― | 3.50% | 4.86% | -0.20% | |
70 Outperform | ¥121.26B | 6.63 | ― | 4.15% | 1.70% | 133.06% | |
63 Neutral | ¥88.04B | 10.65 | ― | 1.24% | 10.37% | 62.23% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |